Evidence map›Paper›PMID 40903494›Full record

ArticleEMBO reports2025

Cargoes move from cis to trans-Golgi compartments and concentrate in the TGN before exiting.

Marinella Pirozzi, Ilenia Agliarulo, Rosaria Di Martino, Vincenzo Manuel Marzullo, Micaela Quarto, Gabriele Turacchio, Galina V Beznoussenko, Domenico Russo, Alberto Luini, Alexander A Mironov and 1 more

Abstract read
In one paragraph

Article in EMBO reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marinella Pirozzi *Institute of Endotypes in Oncology, Metabolism and Immunology "G. Salvatore"-Second Unit (IEOMI-SU), National Research Council of Italy (CNR), Via P. Castellino 111, Napoli, Italy. m.pirozzi@ieos.cnr.it.ORCID 0000-0002-1714-2000
Ilenia Agliarulo *Institute of Endotypes in Oncology, Metabolism and Immunology "G. Salvatore"-Second Unit (IEOMI-SU), National Research Council of Italy (CNR), Via P. Castellino 111, Napoli, Italy.ORCID 0000-0002-0565-6493
Rosaria Di MartinoInstitute of Endotypes in Oncology, Metabolism and Immunology "G. Salvatore"-Second Unit (IEOMI-SU), National Research Council of Italy (CNR), Via P. Castellino 111, Napoli, Italy.
Vincenzo Manuel MarzulloInstitute of Endotypes in Oncology, Metabolism and Immunology "G. Salvatore"-Second Unit (IEOMI-SU), National Research Council of Italy (CNR), Via P. Castellino 111, Napoli, Italy.ORCID 0000-0001-8746-1296
Micaela QuartoIFOM ETS, The AIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy.
Gabriele TuracchioInstitute of Endotypes in Oncology, Metabolism and Immunology "G. Salvatore"-Second Unit (IEOMI-SU), National Research Council of Italy (CNR), Via P. Castellino 111, Napoli, Italy.ORCID 0000-0002-0959-3266
Galina V BeznoussenkoIFOM ETS, The AIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy.
Domenico RussoInstitute of Endotypes in Oncology, Metabolism and Immunology "G. Salvatore"-Second Unit (IEOMI-SU), National Research Council of Italy (CNR), Via P. Castellino 111, Napoli, Italy. d.russo@ieos.cnr.it.ORCID 0000-0003-2171-657X
Alberto LuiniInstitute of Endotypes in Oncology, Metabolism and Immunology "G. Salvatore"-Second Unit (IEOMI-SU), National Research Council of Italy (CNR), Via P. Castellino 111, Napoli, Italy. a.luini@ieos.cnr.it.ORCID 0000-0002-8729-2549
Alexander A MironovIFOM ETS, The AIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy. alexandre.mironov@ifom.eu.ORCID 0000-0003-2308-1651
Seetharaman ParashuramanInstitute of Endotypes in Oncology, Metabolism and Immunology "G. Salvatore"-Second Unit (IEOMI-SU), National Research Council of Italy (CNR), Via P. Castellino 111, Napoli, Italy. raman.sp@cnr.it.ORCID 0000-0001-5113-4592

Funding

AIRC, Italy IG 15767AIRC, Italy IG 20786Ministero dell'Università e della Ricerca (MUR) 2022MZJR9XMinistero dell'Università e della Ricerca (MUR) CN00000041 CN3 RNAMinistero dell'Università e della Ricerca (MUR) FOE-EuroBioimagingMinistero dell'Università e della Ricerca (MUR) P2022MMPXHMinistero dell'Università e della Ricerca (MUR) P2022YA3LL
6 · The paper itself

Abstract

The classical models of intra-Golgi transport envision a movement of cargoes from cis- to trans-Golgi, followed by their sorting at the trans-Golgi network (TGN). During this vectorial transport, the cargoes are processed by sequentially acting glycosylation enzymes. A number of studies challenged the vectorial transport model and proposed alternative transport routes bypassing either directional transport or the TGN. We have re-visited intra-Golgi transport using varied cargo synchronization protocols, employing both imaging and biochemical methods. We find that cargoes move vectorially across the Golgi stack and reach the TGN. Cell type-dependent variations in transport kinetics and the limited resolution of fluorescence microscopy could have influenced earlier discrepant interpretations. Further, we find that exit from TGN is a rate-limiting step leading to the accumulation of cargoes there before their monoexponential exit. These findings support an intriguing model of intra-Golgi transport, which involves classical vectorial transport across the Golgi stack followed by a non-maturation-based transport from the stack to the TGN.

Indexed as

Golgi Apparatustrans-Golgi NetworkAnimalsBiological TransportHeLa CellsHumansMicroscopy, FluorescenceProtein TransportGolgiMembrane TransportTGN

Identifiers

PMID40903494
PMCPMC12508209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.